Abstract
Current imaging procedures for prostate cancer including positron emission tomography (PET) exhibit considerable limitations and are not always able to meet the diagnostic needs. Recently, a 68Gallium-labeled ligand of the prostate-specific membrane antigen (68Ga-PSMA) has been introduced in PET-imaging of prostate cancer with first promising results. Due to relatively exclusive expression of PSMA in prostatic tissue as well as increased expression in prostate cancer, 68 Ga-PSMA was reported to exhibit a favorable lesion to background ratio. Together with the novel development of combined PET/MRI, the combination of excellent morphological detail, multiparametric functional information, and molecular PET data might lead to a significant improvement in detection of prostate cancer. We present an exemplarily case of primary staging using multiparametric 68Ga-PSMA PET/MR by combining molecular and structural information.
References
Afshar-Oromieh A, Zechmann CM, Malcher A, Eder M, Linhart HG (2014) Comparison of PET imaging with a 68 Ga-labelled PSMA ligand and 18F-choline-based PET/CT for the diagnosis of recurrent prostate cancer. Eur. J. Nucl. Med. Mol. Imaging. 41:11–20
Afshar-Oromieh A, Haberkorn U, Schlemmer HP, et al. (2014) Comparison of PET/CT and PET/MRI hybrid systems using a 68 Ga-labelled PSMA ligand for the diagnosis of recurrent prostate cancer: initial experience. Eur. J. Nucl. Med. Mol. Imaging. 41:887–897
Afshar-Oromieh A, Haberkorn U, Eder M, Eisenhut M, Zechmann CM (2012) [68 Ga] Gallium-labelled PSMA ligand as superior PET tracer for the diagnosis of prostate cancer: comparison with 18 F-FECH. Eur. J. Nucl. Med. Mol. Imaging 39(6):1085–1086
Metz S, Ganter C, Lorenzen S, et al. (2010) Phenotyping of tumor biology in patients by multimodality multiparametric imaging: relationship of microcirculation, alphavbeta3 expression, and glucose metabolism. J Nuc Med 51:1691–1698
Chen Y-J, Chu W-C, Pu Y-S, et al. (2012) Washout gradient in dynamic contrast-enhanced MRI is associated with tumor aggressiveness of prostate cancer. J. Magn. Reson. Imaging JMRI. 36:912–919
Oto A, Yang C, Kayhan A, et al. (2011) Diffusion-weighted and dynamic contrast-enhanced MRI of prostate cancer: correlation of quantitative MR parameters with Gleason score and tumor angiogenesis. AJR Am. J. Roentgenol 197:1382–1390
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Eiber, M., Nekolla, S.G., Maurer, T. et al. 68Ga-PSMA PET/MR with multimodality image analysis for primary prostate cancer. Abdom Imaging 40, 1769–1771 (2015). https://doi.org/10.1007/s00261-014-0301-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00261-014-0301-z